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Human Arkadia is a nuclear protein consisted of 989 amino acid residues, with a characteristic RING domain in its C-terminus.
The RING domain harbours the E3 ubiquitin ligase activity needed by Arkadia to ubiquitinate its substrates such as negative
regulators of TGF-β signaling. The RING ﬁnger domain of Arkadia is a RING-H2 type and its structure and stability is strongly
dependent on the presence of two bound Zn(II) ions attached to the protein frame through a deﬁned Cys3-His2-Cys3 motif.
In the present paper we transform the RING-H2 type of Arkadia ﬁnger domain to nonnative RING sequence, substituting the
zinc-binding residues Cys
955 or His
960 to Arginine, through site-directed mutagenesis. The recombinant expression, in Escherichia
coli, of the mutants C955R and H960R reveal signiﬁcant lower yield in respect with the native polypeptide of Arkadia RING-H2
ﬁnger domain. In particular, only the C955R mutant exhibits expression yield suﬃcient for recombinant protein isolation and
preliminary studies. Atomic absorption measurements and preliminary NMR data analysis reveal that the C955R point mutation
in the RING Finger domain of Arkadia diminishes dramatically the zinc binding aﬃnity, leading to the breakdown of the global
structural integrity of the RING construct.
1.Introduction
RING ﬁnger is a characteristic protein sequence motif that
was ﬁrst identiﬁed in the protein product of the human
gene RING1—Really Interesting New Gene 1—which is
located proximal to the major histocompatibility region
on chromosome 6 [1]. The RING ﬁnger domain is a
cysteine/histidine-rich, zinc-chelating domain thatpromotes
both protein-protein and protein-DNA interactions [2].
It is deﬁned as Cys1-Xaa2-Cys2-Xaa9–39-Cys3-Xaa1–3-His4-
Xaa2-3-Cys/His5-Xaa2-Cys6-Xaa4–48-Cys7-Xaa2-Cys8 (where
Xaacanbeanyaminoacidresidue).Twozincatomsarecom-
plexed by the cysteine/histidine residues in a “cross-brace”
manner, to provide correct folding and biological activity to
the RING domain Figure 1(a) [3, 4]. The distinctive cross-
brace arrangement of the two tetrahedral zinc binding sites
endows the RING domain with a globular conformation,
characterized by a central α-helix and variable-length loops
separated by several small β-strands. RING ﬁnger motifs
are further subdivided, depending on whether a cysteine or
histidine residue is found at Cys/His5 within the motif. Thus
they are classiﬁed as being either a RING-HC (Cys5)o ra
RING-H2 (His5) type. The metal binding properties of some
RINGﬁngerdomainshavebeeninvestigatedinapreliminary
manner, using synthetic peptides that bear the amino acid
sequence of BRCA1 and HDM2 [5, 6]. It is well-established
that RING ﬁngers can also bind other than zinc metal ions,
such as cobalt (II) and cadmium (II) [7–9]
Human Arkadia is a nuclear protein of 994 amino acid
open reading frame (ORF) that exhibits no sequence simi-
larity with any other known protein apart from the RING-
H2 ﬁnger topology in its C-terminal region [10]. Mouse
Arkadia ORF diﬀers in length by 5 residues (989 aa) but
their C-terminal 124 residue segments bear identical amino
acid sequence. Arkadia has been shown to function as an E3
ubiquitin ligase [11]. E3 ligases participate actively at the last
step of the protein degradation through the ubiquitination
pathway [12, 13]. Additionally, RING E3 ubiquitin ligases2 Bioinorganic Chemistry and Applications
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Figure 1:(a)TheschematicstructureofaRINGﬁngerdomainshowingthe“cross-brace”arrangementofthetwozincbindingsites;(b)The
amino acid sequence of the RING ﬁnger domain of mouse Arkadia; (c) the mutation sites, C955R and H960R, in the sequence of Arkadia
RING Finger domain.
play an essential role in the regulation of many biological
processes and defects in some of them are involved in cancer
development. Thus, RING E3 ligases represent a potential
molecular target for disease intervention in mechanism-
driven drug discovery [14–17]. Arkadia is the ﬁrst example
of a RING E3 ubiquitin ligase that positively regulates TGF-
β family signaling. The RING-H2 domain harbours the E3
ubquitin ligase activity required by Arkadia to ubiquitinate
variousnegativeregulatorsofT GF-β[11,18–20].Recentlyan
eﬃcient method for expression in Escherichia coli and puriﬁ-
cation of recombinant Arkadia RING-H2 ﬁnger domain
as a soluble protein was reported [21]. Preliminary NMR
data analysis of the Arkadia RING Finger suggests a ββαβ-
like topology typical of RING ﬁnger domains. Additionally,
NMR experimental evidence indicates that proper zinc
incorporation is a major determinant for the RING ﬁnger
domain structure and stability [21].
Each type of RING domain exhibits unique structural
characteristics,whichmayaﬀectthespeciﬁcityoftherecruit-
ment of E2 enzymes or substrate recognition. Furthermore,
substitution of various native amino acids, especially the
zinc-binding residues, resulted in the signiﬁcant loss of
ubiquitination capacity, as shown in various E3 ligases such
as BRCA1, HDM2 and many other RING ﬁnger domain-
containing proteins. Substitution of zinc-binding amino
acids with residues by atom-donors with lower aﬃnity
to zinc metal ion, results in a collapsed RING ﬁnger
structure or in a conformational alteration that prevents
RING from interacting with E2. Thus assembly of E2 and
E3 into a productive complex, a key component in theBioinorganic Chemistry and Applications 3
ubiquitination pathway, is misformed. Herein we present
the production of two nonnative RING ﬁnger domains of
mouse Arkadia: C955R and H960R Figure 1(b), through
site-directed mutagenesis. The recombinant expression in
Escherichia coli of the mutants C955R and H960R reveals
signiﬁcant lower yield in respect with the native polypeptide
of Arkadia RING-H2 ﬁnger domain. Only the C955R
mutant exhibits expression yield suﬃcient for recombinant
protein isolation and the protocol applied was based on
that used for the wt of Arkadia RING-H2 ﬁnger domain
[21]. Since zinc binding is considered to be critical to
proper folding and activity of the RING-H2 domain
of Arkadia, the nonnative polypeptides were expressed
in zinc-loaded growth media. Zinc contents of the wt
and mutant C955R RING construct were determined by
Atomic Absorption measurements. Finally, the folding state
and the structural integrity of the holo-RING constructs
were monitored through 1Ha n d2 D1H-15N-HSQC spec-
troscopy.
2.MaterialsandMethods
2.1. Plasmids, Bacterial Strains, and Growth Media. E. coli
DH5α (Invitrogen) was used as the host strain for cloning
and plasmid propagation and E.coli BL21(DE3) (Stratagene)
as the host strain for the expression vector pGEX–4T-1
(Amersham Biosciences). Both strains were routinely grown
in Luria-Bertani (LB hereafter) broth or on plates of LB agar,
supplemented with ampicillin (100μg/ml) for both trans-
formedDH5αandBL21(DE3)strains.Inductionwascarried
out in M9 medium supplemented with 2ml/l of solution Q
(40mM HCl, 50mg/l FeCl2·4H2O, 184mg/l CaCl2·2H2O,
64mg/l H3BO3,1 8 m g / lC o C l 2·6H2O, 340mg/l ZnCl2,
605mg/l Na2Mo4·2H2O, 40 mg/l MnCl2·4H2O) and 10ml/l
ofvitaminmix(500mg/lthiamine,100mg/lbiotin,100mg/l
choline chloride, 100mg/l folic acid, 100mg/l niacinamide,
100mg/l pantothenic acid, 100mg/l pyridoxal, 10mg/l
riboﬂavin).
2.2. Cloning, Expression, Puriﬁcation, and Isotopic Labeling of
Arkadia RING Constructs. T h ep r o t o c o la d o p t e dt oe x p r e s s
and purify the nonnative RING constructs of Arkadia was
essentially the same as that previously reported to produce
the wt of the RING-H2 construct [10]. The expression
plasmids for the presented mutants were obtained from
that of wt RING-H2 through the Quickchange (Stratagene)
mutagenesis kit. 15N isotopic labeling of the mutant C955R
was obtained using M9 medium supplemented with 2g/l
15NH4Cl as nitrogen source.
2.3. Preliminary Protein Characterization. The purity of
all polypeptides was checked by SDS-PAGE in 17%
polyacrylamide gels after staining of protein bands with
Coomassie Blue R-250. The concentration of RING domains
of Arkadia was determined by using two methods: the
ﬁrst is based on the extinction coeﬃcients at 280nm of
each construct, as estimated by PROTPARAM software
(http://www.expasy.org/tools/protparam.html/) and the sec-
ond, which is more accurate, on the Quick start Bradford
protein assay (BIORAD) [22].
2.4. Atomic Absorption Spectrometry. Elemental analysis for
zinc was performed employing Atomic Absorption Spec-
trometry (Perkin Elmer AAnalyst 300). The zinc content was
measured in wt RING-H2 and the mutant C955R RING
c o n s t r u c t s .I no r d e rt oe x c l u d ea n ym a t r i xe ﬀect in zinc
measurements, the standard addition method was applied
[23]. Four samples were prepared for the ﬁrst construct,
the unspiked and three aliquots (spiked) to which known
amounts of the analyte zinc from a stock standard solution
(AA Panreac 1.000 ± 0.002g/l Zn) were added (Table 1).
For the nonnative construct, three samples were prepared,
respectively: the unspiked and two spiked. The spiked
concentration ranged from 0 (unspiked sample) to 0.6ppm.
The volume was kept equal for all samples by means of
addition of PBS buﬀer. Preliminary tests assured that the
overall concentration of zinc was lying within the linear
range of the technique (1ppm). Absorbance of all samples
at the appropriate wavelength (213.9nm) was measured
twice. An appropriate calibration curve for each protein was
constructed (Table 3, Figure 3). The concentration of zinc in
the unspiked samples was determined, dividing the intercept
by the slope of calibration curve [23].
2.5. NMR Spectroscopy. 1D 1H-NMR and 1H-15NH S Q C
spectra were recorded at 298K on a Bruker Avance 600MHz
spectrometer, equipped with a cryogenically cooled pulsed-
ﬁeld gradient triple-resonance probe (TXI) and on a Bruker
Avance DRX 400MHz, equipped with two multinuclear
broadband probes (inverse BBI and direct BBO). 1H1 D
spectra were acquired in the 16ppm spectral width using a
variety of pulse sequence for water suppression and spectra
werecalibratedrelativelytothewaterprotonresonances.The
2D 15N HSQC spectra were acquired using a spectral width
of 40ppm for ω1 and 8ppm for ω2. The NMR samples
contained 1mM and 0.2mM protein of wt Arkadia and
mutant construct C955R, respectively, in 50mM phosphate
buﬀer, pH = 7, in the presence of 90% H2O/10% D2O.
3. Results and Discussion
The C-terminal RING ﬁnger domains of wt and Arkadia
mutants were expressed in M9 minimal growth media
supplemented with ZnCl2. Both of the mutants: C955R and
H960R, reveal remarkably lower expression yield in respect
with the native polypeptide of Arkadia RING-H2 ﬁnger
domain. Small-scale test expression of RING constructs in
the absence of ZnCl2 suggests that additional zinc enrich-
ment of growth media does not aﬀect the expression yield of
soluble RING constructs. In Figure 2, it is presented the total
cell lysate of wt (a), the mutant C955R (b) and H960R (c),
at 37
◦C with ZnCl2 at a ﬁnal concentration 100μM. Finally,
from the above mutants, the expression yield of the C955R
mutant was suﬃcient for recombinant protein isolation and
preliminary studies.4 Bioinorganic Chemistry and Applications
Table 1: Samples of each construct spiked with Zn prepared and analyzed.
Sample Volume of the unknown protein sample used (μl) Final volume of the sample (ml) Spiked Concentration of Zn (ppm)
RING-H2 construct
A 15.0 5.0 0
B 15.0 5.0 0.2
C 15.0 5.0 0.4
D 15.0 5.0 0.6
Mutant RING construct (C955R)
A9 . 0 2 . 0 0
B 9.0 2.0 0.1
C 9.0 2.0 0.2
Table 2: Cumulative results of zinc: protein ratio for the samples analyzed.
Protein sample Zn concentration
(mM)
Protein concentration
(mM)
Zn : protein
ratio
RING-H2 1.04300 (±0.00460) 0.498 (±0.001) 2.094
Mutant RING
(C955R) 0 0.201 (±0.001) 0
(a) (b) (c)
Figure 2: The total cell lysate of wt (a), the mutant C955R (b), and
H960R (c) at 37
◦C with ZnCl2 at a ﬁnal concentration 100μM.
Elemental analysis for zinc was performed employing
Atomic Absorption Spectrometry. A calibration curve for
each protein sample (Figure 3) was constructed as described
in Section 2. The concentration of zinc in the unspiked
sample of both constructs was determined, dividing the
intercept by the slope of the calibration curves [23]( T a b l e3).
The concentration of zinc in the initial samples of 0.5mM
RING-H2 and 0,2mM C955R mutant of Arkadia was
calculated to be 1mM and 0mM, respectively, (Table 2).
It should, also, be stressed that the zinc content of the
constructs remained stable in excess of ZnCl2 in the growth
media (>100μM). The atomic absorption measurements of
the native RING construct suggest a stoichiometry of two
zinc ions per molecule, a value that is in agreement with
the classic binding properties of RING ﬁngers. However, the
elemental analysis of the C955R mutant suggests that the
mutated construct does not bind zinc at all, indicating that
the substitution of one of the three cysteines in the second
tetrahedral zinc binding motif abolishes the global metal
binding capacity of the hole polypeptide.
It is known that the protein structure of the Arkadia
zinc loaded wt RING-H2 domain is well folded and the zinc
incorporation is a major determinant for its structure and
stability [17–21]. Indeed, when EDTA was added to a sample
of the Arkadia RING ﬁnger domain at a 1:1 molar ratio
with respect to Zn(II) substantial changes were observed for
an u m b e ro fr e s i d u e si na1H-15N HSQC spectrum. Further
addition of EDTA up to a ﬁnal Zn:EDTA molar ratio of
1:2 led to dramatic changes in the 1H-15N HSQC typical for
structureless polypeptide [21]. The 1D 1H-NMR spectrum
of C955R mutant (Figure 4(a)) and its comparison with the
1D NMR spectrum of the wt (Figure 4(b)) suggests that the
C955R RING construct is not a folded protein.
Heteronuclear NMR spectroscopy, and especially 2D 1H-
15N-HSQC experiments provides the ﬁngerprint spectrum
of each polypeptide and are diagnostic tools for the folding
properties and aggregation state of recombinant proteins.
Additionally, this technique can probe ﬁne structural rear-
rangements upon amino acids substitutions and for this
reason it is applied to probe the eﬀect of C955R mutation.
Indeed, the 1H-15N-HSQC exhibits dramatic changes in
respect with the spectrum of the native RING construct,
with no signal dispersion of the backbone amide groups
(Figure 4). This remarkable lack of the chemical shift
dispersion is almost identical to that observed in the HSQC
spectrum of the unstructured wt RING construct, due to
the presence of EDTA excess [21]. EDTA is a powerful metal
chelating agent and competes the RING polypeptide for zinc
binding. Excess of EDTA in RING Finger solution uptakes
the zinc ion and RING polypeptide structure collapses as
evidencedbytheHSQC.MutationoftheCys955 byArgseems
to result to an unstructured polypeptide that has abolished
the zinc binding ability.
The substitution of the His960 and Cys955 residues by an
Arg was driven by the fact that Arg, according to Blosum
matrix, is among the residues with the higher probability toBioinorganic Chemistry and Applications 5
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Figure 3: Calibration curves for the additions of zinc in (a) RING-H2 and (b) mutant RING (C955R) of Arkadia.
Table 3: Linear regression data for the calibration curves.
Protein sample Intercept (A) Slope (B) Correlation Coeﬃcient (R)
RING-H2 0.02220 (±0.00009) 0.10850 (±0.00240) 0.99951 (±0.00107)
Mutant-RING (C955R) −0.00002 (±0.00004) 0.14500 (±0.00289) 0.99980 (±0.00004)
substitute His in polypeptide sequence, due to the similar
length and nature of its side chain and its basic character.
Additionally, its linear side-chain is not expected to impose
signiﬁcant steric interaction that may alter dramatically
the spatial geometry of the other potential Zn(II) binding
residues (three Cysteines). Since the expression yield of
the H960R mutant was very low for protein isolation,
preliminary studies were performed only for the C955R
mutant. It is proposed that the new mutated motif does not
bind zinc at all, in contrast to the stoichiometry of two zinc
ions per molecule for the native RING construct. Although
the alteration occurred in the second binding motif, both
binding sites are losing their metal binding capacity. Addi-
tionally, NMR spectroscopy indicates that C955R mutant of
RING Arkadia undergoes signiﬁcant structural rearrange-
ments losing its proper folding, in respect with the native
polypeptide. This result may provide new insights into the
sequential metal loading by the two tetrahedral binding sites
of the RING-H2 domain of Arkadia. Since the net eﬀect
of the C955R substitution is the collapse of the structure
it is suggested that the second site may be an important
regulator that aﬀects the formation of the ﬁrst site and the
overall metal-dependent folding of the polypeptide. In the
past, the sequential binding was considered to be a general
characteristic of RING ﬁnger domains, but its biological
signiﬁcance has not yet been established [5, 24, 25]. One
characteristic example is the metal binding properties of
peptide corresponding to the RING ﬁnger domain from the
tumor suppressor gene product BRCA1. It is found that the
above metal binding is thermodynamically sequential with
cobalt(II) almost saturating one of the two sites in each
polypeptide prior to binding to the other site. Analysis of
the absorption spectra due to cobalt(II) bound to the two
sites revealed that the higher aﬃnity site is comprised of four
cysteinate ligands whereas the lower aﬃnity site has three
cysteinate and one histidine ligands. Upon binding a metal
ion to site 1 (Cys4), the peptide becomes somewhat more
structured and, perhaps, more rigid in a manner that aﬀects
the regions involved in forming site 2 (Cys3His). This, in
turn, increases the diﬃculty in binding a metal ion to site 2,
leadingtotheobservedanticooperativity[5].Thesamemetal
binding properties were found in the RING ﬁnger domain
of HDM2 C-terminal domain. In this case the metal binds
to the higher-aﬃnity binding site were monitored through
ﬂuorescence energy transfer, revealing two binding events
separately: the stronger binding site C4 and the weaker one
C3H. Furthermore, synthetic knockout mutants not only
enabled to assign the coordinating residues in the HDM2
RING ﬁnger domain but also revealed that metal binding to
HDM2 was also anticooperative [6].
In summary, we reinforce the theory that substitution
of zinc-binding amino acids in RING ﬁnger domains may
possesses an immense role in the biochemical and biological
activity of RING Finger E3 ligases. Herein, we demonstrate
that even one point mutation (C955R) in the RING ﬁnger
domain of Arkadia can have a dramatic eﬀect in the domain
structure, leading to the breakdown of the global structural
integrity of the RING construct. This phenomenon is6 Bioinorganic Chemistry and Applications
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Figure 4: The 1D 1H-NMR of amide proton resonances (7,5–
10ppm) and 1H-15N HSQC of the mutant (a) and the native RING
(b).
expected to prevent the formation of a E3-E2 productive
complex and ﬁnally to reduce its ubiquitin ligase activity.
In the past, similar results have been reported regarding
mutants in the zinc binding motif of HDM2 (429–491).
RING ﬁnger domain (such as His452Ala and His457Ala)
was studied through NMR spectroscopy revealing a lack
of dispersion and broad resonances in 15N-HSQC spectra,
characteristic of unfolded protein [26]. The correlation
between mutations in the RING ﬁnger domain of E3 ligases
and their ubiquitination activity was well established in
the past through the detection of mutations within the
BRCA1 RING domain that predispose to cancer due to the
abolishment of BRCA1 ligase activity [27]. Furthermore, site
mutationsintheRINGﬁngerofE3ligasesareassociatedwith
various consequences in biological processes such as their
unusual distribution in the cell, like the large cytoplasmic
and nuclear inclusion of the two mutant isoforms of Parkin
RING ﬁnger protein [28]. In this light, the veriﬁcation of
this probable occurrence of a sequential metal binding by the
wt/mutant of RING ﬁnger domains of Arkadia and the study
of their mechanism remain to be done.
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RING: Really interesting new gene
TGF-β: Transforming growth factor β
NMR: Nuclear Magnetic Resonance.
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